Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)

• Company Description    GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. Number of Employees: 697

• Price / Volume Information    Yesterday's Closing Price: $2.65 Daily Weekly Monthly 20 Day Moving Average: 1,720,114 shares Shares Outstanding: 342.57 (millions) Market Capitalization: $907.82 (millions) Beta: 1.54 52 Week High: $5.81 52 Week Low: $1.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 15.22% 9.59% 12 Week 33.17% 23.11% Year To Date -2.21% -13.15%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2701 OLYMPIC BOULEVARD - SANTA MONICA,CA 90404 USA ph: 855-268-2822 fax: - ir@goodrx.com http://www.goodrx.com

• General Corporate Information    Officers Wendy Barnes - Chief Executive Officer and President Trevor Bezdek - Chairman Christopher McGinnis - Chief Financial Officer Romin Nabiey - Chief Accounting Officer Christopher Adams - Director Peer Information GoodRx Holdings, Inc. (CHCR) GoodRx Holdings, Inc. (ESRX) GoodRx Holdings, Inc. (MYDP) GoodRx Holdings, Inc. (COR) GoodRx Holdings, Inc. (GBCS) GoodRx Holdings, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 38246G108 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 342.57 Most Recent Split Date: (:1) Beta: 1.54 Market Capitalization: $907.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.17 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 9.48% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: 16.06 Trailing 12 Months: 16.56 PEG Ratio: 1.69 Price Ratios Price/Book: 1.46 Price/Cash Flow: 6.62 Price / Sales: 1.15 EPS Growth vs. Year Ago Period: -40.00% vs. Previous Quarter: -25.00% Sales Growth vs. Year Ago Period: -4.42% vs. Previous Quarter: -0.40% ROE 03/31/26 - 7.90 12/31/25 - 9.31 09/30/25 - 9.73 ROA 03/31/26 - 3.23 12/31/25 - 4.38 09/30/25 - 4.79 Current Ratio 03/31/26 - 1.47 12/31/25 - 2.61 09/30/25 - 3.11 Quick Ratio 03/31/26 - 1.47 12/31/25 - 2.61 09/30/25 - 3.11 Operating Margin 03/31/26 - 6.22 12/31/25 - 7.35 09/30/25 - 7.97 Net Margin 03/31/26 - 2.61 12/31/25 - 3.82 09/30/25 - 3.97 Pre-Tax Margin 03/31/26 - 5.78 12/31/25 - 7.10 09/30/25 - 6.71 Book Value 03/31/26 - 1.82 12/31/25 - 1.81 09/30/25 - 1.77 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.78 12/31/25 - 0.78 09/30/25 - 0.81 Debt-to-Capital 03/31/26 - 43.68 12/31/25 - 43.95 09/30/25 - 44.63

Powered by Zacks Investment Research ©